TY - JOUR PY - 2000 DA - 2000// TI - Management of malignant pleural effusions JO - Am J Respir Crit Care Med VL - 162 UR - https://doi.org/10.1164/ajrccm.162.5.ats8-00 DO - 10.1164/ajrccm.162.5.ats8-00 ID - ref1 ER - TY - CHAP AU - Light, R. W. ED - Light, R. W. PY - 2001 DA - 2001// TI - Pleural effusions related to metastatic malignancies BT - Pleural diseases PB - Lippincott Williams and Wilkins CY - Philadelphia ID - Light2001 ER - TY - JOUR AU - Rodriguez-Panadero, F. AU - Montes-Worboys, A. PY - 2012 DA - 2012// TI - Mechanism of pleurodesis JO - Respiration VL - 83 UR - https://doi.org/10.1159/000335419 DO - 10.1159/000335419 ID - Rodriguez-Panadero2012 ER - TY - JOUR AU - Laiho, M. AU - Keski-Oja, J. PY - 1989 DA - 1989// TI - Growth factors in the regulation of pericellular proteolysis: a review JO - Cancer Res VL - 49 ID - Laiho1989 ER - TY - JOUR AU - Rangaswami, H. AU - Bulbule, A. AU - Kundu, G. C. PY - 2006 DA - 2006// TI - Osteopontin: role in cell signaling and cancer progression JO - Trends Cell Biol VL - 16 UR - https://doi.org/10.1016/j.tcb.2005.12.005 DO - 10.1016/j.tcb.2005.12.005 ID - Rangaswami2006 ER - TY - JOUR AU - Bellahcene, A. AU - Castronovo, V. AU - Ogbureke, K. U. AU - Fisher, L. W. AU - Fedarko, N. S. PY - 2008 DA - 2008// TI - Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer JO - Nat Rev Cancer VL - 8 UR - https://doi.org/10.1038/nrc2345 DO - 10.1038/nrc2345 ID - Bellahcene2008 ER - TY - JOUR AU - Tuck, A. B. AU - Arsenault, D. M. AU - O’Malley, F. P. AU - Hota, C. AU - Ling, M. C. AU - Wilson, S. M. AU - Chambers, A. F. PY - 1999 DA - 1999// TI - Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells JO - Oncogene VL - 18 UR - https://doi.org/10.1038/sj.onc.1202799 DO - 10.1038/sj.onc.1202799 ID - Tuck1999 ER - TY - JOUR AU - Yano, S. AU - Shinohara, H. AU - Herbst, R. S. AU - Kuniyasu, H. AU - Bucana, C. D. AU - Ellis, L. M. AU - Fidler, I. J. PY - 2000 DA - 2000// TI - Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells JO - Am J Pathol VL - 157 UR - https://doi.org/10.1016/S0002-9440(10)64828-6 DO - 10.1016/S0002-9440(10)64828-6 ID - Yano2000 ER - TY - JOUR AU - Grove, C. S. AU - Lee, Y. C. G. PY - 2002 DA - 2002// TI - Vascular endothelial growth factor: the key mediator in pleural effusion formation JO - Curr Opin Pulm Med VL - 8 UR - https://doi.org/10.1097/00063198-200207000-00009 DO - 10.1097/00063198-200207000-00009 ID - Grove2002 ER - TY - JOUR AU - Ishikawa, H. AU - Satoh, H. AU - Hasegawa, S. AU - Yazawa, T. AU - Naito, T. AU - Yamashita, Y. T. AU - Ohtsuka, M. AU - Ogata, T. AU - Kamma, H. PY - 1997 DA - 1997// TI - Urokinase-type plasminogen activator in carcinomatous pleural fluid JO - Eur Respir J VL - 10 UR - https://doi.org/10.1183/09031936.97.10071566 DO - 10.1183/09031936.97.10071566 ID - Ishikawa1997 ER - TY - JOUR AU - Chung, C. L. AU - Chen, Y. C. AU - Chang, S. C. PY - 2003 DA - 2003// TI - Effect of repeated thoracentesis on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion JO - Chest VL - 123 UR - https://doi.org/10.1378/chest.123.4.1188 DO - 10.1378/chest.123.4.1188 ID - Chung2003 ER - TY - JOUR AU - Chung, C. L. AU - Chen, C. H. AU - Sheu, J. R. AU - Chen, Y. C. AU - Chang, S. C. PY - 2005 DA - 2005// TI - Proinflammatory cytokines, transforming growth factor-β1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates JO - Chest VL - 128 UR - https://doi.org/10.1016/S0012-3692(15)50413-3 DO - 10.1016/S0012-3692(15)50413-3 ID - Chung2005 ER - TY - JOUR AU - Rodriguez-Panadero, F. AU - Segado, A. AU - Martin Juan, J. AU - Ayerbe, R. AU - Torres Garcia, I. AU - Castillo, J. PY - 1995 DA - 1995// TI - Failure of talc pleurodesis is associated with increased pleural fibrinolysis JO - Am J Respir Crit Care Med VL - 151 UR - https://doi.org/10.1164/ajrccm/151.3_Pt_1.785 DO - 10.1164/ajrccm/151.3_Pt_1.785 ID - Rodriguez-Panadero1995 ER - TY - JOUR AU - Strange, C. AU - Baumann, M. H. AU - Sahn, S. A. AU - Idell, S. PY - 1995 DA - 1995// TI - Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease JO - Am J Respir Crit Care Med VL - 151 UR - https://doi.org/10.1164/ajrccm.151.2.7842213 DO - 10.1164/ajrccm.151.2.7842213 ID - Strange1995 ER - TY - JOUR AU - Davies, C. W. AU - Traill, Z. C. AU - Gleeson, F. V. AU - Davies, R. J. PY - 1999 DA - 1999// TI - Intrapleural streptokinase in the management of malignant multiloculated pleural effusions JO - Chest VL - 115 UR - https://doi.org/10.1378/chest.115.3.729 DO - 10.1378/chest.115.3.729 ID - Davies1999 ER - TY - JOUR AU - Gilkeson, R. C. AU - Silverman, P. AU - Haaga, J. R. PY - 1999 DA - 1999// TI - Using urokinase to treat malignant pleural effusions JO - Am J Roentgenol VL - 173 UR - https://doi.org/10.2214/ajr.173.3.10470923 DO - 10.2214/ajr.173.3.10470923 ID - Gilkeson1999 ER - TY - JOUR AU - Maskell, N. A. AU - Gleeson, F. V. PY - 2003 DA - 2003// TI - Effect of intrapleural streptokinase on a loculated malignant pleural effusion JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/ENEJMicm020531 DO - 10.1056/ENEJMicm020531 ID - Maskell2003 ER - TY - JOUR AU - Hsu, L. H. AU - Soong, T. C. AU - Feng, A. C. AU - Liu, M. C. PY - 2006 DA - 2006// TI - Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients JO - J Thorac Oncol VL - 1 UR - https://doi.org/10.1016/S1556-0864(15)31612-9 DO - 10.1016/S1556-0864(15)31612-9 ID - Hsu2006 ER - TY - JOUR AU - Thornton, R. H. AU - Miller, Z. AU - Covey, A. M. AU - Brody, L. AU - Sofocleous, C. T. AU - Solomon, S. B. AU - Getrajdman, G. I. PY - 2010 DA - 2010// TI - Tunneled pleural catheters for treatment of recurrent malignant pleural effusion following failed pleurodesis JO - J Vasc Interv Radiol VL - 21 UR - https://doi.org/10.1016/j.jvir.2010.01.021 DO - 10.1016/j.jvir.2010.01.021 ID - Thornton2010 ER - TY - JOUR AU - Zorio, E. AU - Gilabert-Estellés, J. AU - España, F. AU - Ramón, L. A. AU - Cosín, R. AU - Estellés, A. PY - 2008 DA - 2008// TI - Fibrinolysis: the key to new pathogenetic mechanisms JO - Curr Med Chem VL - 15 UR - https://doi.org/10.2174/092986708783955455 DO - 10.2174/092986708783955455 ID - Zorio2008 ER - TY - JOUR AU - Satoh, H. AU - Kamma, H. AU - Ogata, T. AU - Hasegawa, S. PY - 1994 DA - 1994// TI - Local production of plasminogen activator inhibitor-1 in carcinomatous pleuritis JO - Acta Oncol VL - 33 ID - Satoh1994 ER - TY - JOUR AU - Shetty, S. AU - Bdeir, K. AU - Cines, D. B. AU - Idell, S. PY - 2003 DA - 2003// TI - Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M207445200 DO - 10.1074/jbc.M207445200 ID - Shetty2003 ER - TY - JOUR AU - Jänicke, F. AU - Prechtl, A. AU - Thomssen, C. AU - Harbeck, N. AU - Meisner, C. AU - Untch, M. AU - Sweep, C. G. AU - Selbmann, H. K. AU - Graeff, H. AU - Schmitt, M. PY - 2001 DA - 2001// TI - Randomized adjuvant chemotherapy trial in high-risk lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 JO - J Natl Cancer Inst VL - 93 UR - https://doi.org/10.1093/jnci/93.12.913 DO - 10.1093/jnci/93.12.913 ID - Jänicke2001 ER - TY - JOUR AU - Harbeck, N. AU - Kates, R. E. AU - Schmitt, M. PY - 2002 DA - 2002// TI - Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.20.4.1000 DO - 10.1200/JCO.20.4.1000 ID - Harbeck2002 ER - TY - JOUR AU - Hsu, L. H. AU - Liu, K. J. AU - Tsai, M. F. AU - Wu, C. R. AU - Feng, A. C. AU - Chu, N. M. AU - Kao, S. H. PY - 2015 DA - 2015// TI - Estrogen adversely affects the prognosis of patients with lung adenocarcinoma JO - Cancer Sci VL - 106 UR - https://doi.org/10.1111/cas.12558 DO - 10.1111/cas.12558 ID - Hsu2015 ER - TY - JOUR AU - Mack, P. C. AU - Redman, M. W. AU - Chansky, K. AU - Williamson, S. K. AU - Farneth, N. C. AU - Lara, P. N. AU - Franklin, W. A. AU - Le, Q. T. AU - Crowley, J. J. AU - Gandara, D. R. PY - 2008 DA - 2008// TI - Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG study S0003 JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2008.17.0662 DO - 10.1200/JCO.2008.17.0662 ID - Mack2008 ER - TY - JOUR AU - Chang, Y. S. AU - Kim, H. J. AU - Chang, J. AU - Ahn, C. M. AU - Kim, S. K. AU - Kim, S. K. PY - 2007 DA - 2007// TI - Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer JO - Lung Cancer VL - 57 UR - https://doi.org/10.1016/j.lungcan.2007.04.005 DO - 10.1016/j.lungcan.2007.04.005 ID - Chang2007 ER - TY - JOUR AU - Isa, S. I. AU - Kawaguchi, T. AU - Teramukai, S. AU - Minato, K. AU - Ohsaki, Y. AU - Shibata, K. AU - Yonei, T. AU - Hayashibara, K. AU - Fukushima, M. AU - Kawahara, M. AU - Furuse, K. AU - Mack, P. C. PY - 2009 DA - 2009// TI - Serum osteopontin levels are highly prognostic for survival in advanced non-small cell lung cancer JO - J Thorac Oncol VL - 4 UR - https://doi.org/10.1097/JTO.0b013e3181ae2844 DO - 10.1097/JTO.0b013e3181ae2844 ID - Isa2009 ER - TY - JOUR AU - Blasberg, J. D. AU - Pass, H. I. AU - Goparaju, C. M. AU - Flores, R. M. AU - Lee, S. AU - Donington, J. S. PY - 2010 DA - 2010// TI - Reduction of elevated plasma osteopontin levels with resection of non-small cell lung cancer JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.25.5711 DO - 10.1200/JCO.2009.25.5711 ID - Blasberg2010 ER - TY - JOUR AU - Cui, R. AU - Takahashi, F. AU - Ohashi, R. AU - Yoshioka, M. AU - Gu, T. AU - Tajima, K. AU - Unnoura, T. AU - Iwakami, S. AU - Hirama, M. AU - Ishiwata, T. AU - Iwase, A. AU - Takahashi, K. PY - 2009 DA - 2009// TI - Osteopontin is involved in the formation of malignant pleural effusion in lung cancer JO - Lung Cancer VL - 63 UR - https://doi.org/10.1016/j.lungcan.2008.06.020 DO - 10.1016/j.lungcan.2008.06.020 ID - Cui2009 ER - TY - JOUR AU - Song, G. AU - Cai, Q. F. AU - Mao, Y. B. AU - Ming, Y. L. AU - Bao, S. D. AU - Ouyang, G. L. PY - 2008 DA - 2008// TI - Osteopontin promotes ovarian cancer progression and cell survival and increases HIF-1alpha expression through the PI3-K/Akt pathway JO - Cancer Sci VL - 99 ID - Song2008 ER - TY - JOUR AU - Shijubo, N. AU - Uede, T. AU - Kon, S. AU - Maeda, M. AU - Segawa, T. AU - Imada, A. AU - Hirasawa, M. AU - Abe, S. PY - 1999 DA - 1999// TI - Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma JO - Am J Respire Crit Care Med VL - 160 UR - https://doi.org/10.1164/ajrccm.160.4.9807094 DO - 10.1164/ajrccm.160.4.9807094 ID - Shijubo1999 ER - TY - JOUR AU - Hirama, M. AU - Takahashi, F. AU - Takahashi, K. AU - Akutagawa, S. AU - Shimizu, K. AU - Soma, S. AU - Shimanuki, Y. AU - Nishio, K. AU - Fukuchi, Y. PY - 2003 DA - 2003// TI - Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth JO - Cancer Lett VL - 198 UR - https://doi.org/10.1016/S0304-3835(03)00286-6 DO - 10.1016/S0304-3835(03)00286-6 ID - Hirama2003 ER - TY - JOUR AU - Chakraborty, G. AU - Jain, S. AU - Kundu, G. C. PY - 2008 DA - 2008// TI - Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-2126 DO - 10.1158/0008-5472.CAN-07-2126 ID - Chakraborty2008 ER - TY - JOUR AU - Tuck, A. B. AU - Hota, C. AU - Chambers, A. F. PY - 2001 DA - 2001// TI - Osteopontin (OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent JO - Breast Cancer Res Treat VL - 70 UR - https://doi.org/10.1023/A:1013095329825 DO - 10.1023/A:1013095329825 ID - Tuck2001 ER - TY - JOUR AU - Das, R. AU - Philip, S. AU - Mahabeleshwar, G. H. AU - Bulbule, A. AU - Kundu, G. C. PY - 2005 DA - 2005// TI - Osteopontin: it’s role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression JO - IUBMB Life VL - 57 UR - https://doi.org/10.1080/15216540500159424 DO - 10.1080/15216540500159424 ID - Das2005 ER - TY - JOUR AU - Mi, Z. AU - Guo, H. AU - Wai, P. Y. AU - Gao, C. AU - Kuo, P. C. PY - 2006 DA - 2006// TI - Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells JO - Carcinogenesis VL - 27 UR - https://doi.org/10.1093/carcin/bgi352 DO - 10.1093/carcin/bgi352 ID - Mi2006 ER - TY - JOUR AU - Alexander, R. A. AU - Prager, G. W. AU - Mihaly-Bison, J. AU - Uhrin, P. AU - Sunzenauer, S. AU - Binder, B. R. AU - Schütz, G. J. AU - Freissmuth, M. AU - Breuss, J. M. PY - 2012 DA - 2012// TI - VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution JO - Cardiovasc Res VL - 94 UR - https://doi.org/10.1093/cvr/cvs017 DO - 10.1093/cvr/cvs017 ID - Alexander2012 ER - TY - JOUR AU - Bifulco, K. AU - Longanesi-Cattani, I. AU - Liguori, E. AU - Arra, C. AU - Rea, D. AU - Masucci, M. T. AU - Rosa, M. AU - Pavone, V. AU - Stoppelli, M. P. AU - Carriero, M. V. PY - 2013 DA - 2013// TI - A urokinase receptor-derived peptide inhibiting VEGF-dependent directional migration and vascular sprouting JO - Mol Cancer Ther VL - 12 UR - https://doi.org/10.1158/1535-7163.MCT-13-0077 DO - 10.1158/1535-7163.MCT-13-0077 ID - Bifulco2013 ER - TY - JOUR AU - Kaneko, T. AU - Konno, H. AU - Baba, M. AU - Tanaka, T. AU - Nakamura, S. PY - 2003 DA - 2003// TI - Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer JO - Cancer Sci VL - 94 UR - https://doi.org/10.1111/j.1349-7006.2003.tb01350.x DO - 10.1111/j.1349-7006.2003.tb01350.x ID - Kaneko2003 ER - TY - JOUR AU - Ramón, L. A. AU - Gilabert-Estellés, J. AU - Castelló, R. AU - Gilabert, J. AU - España, F. AU - Romeu, A. AU - Chirivella, M. AU - Aznar, J. AU - Estellés, A. PY - 2005 DA - 2005// TI - mRNA quantitative analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using real-time reverse transcription-PCR assay JO - Hum Reprod VL - 20 UR - https://doi.org/10.1093/humrep/deh571 DO - 10.1093/humrep/deh571 ID - Ramón2005 ER - TY - JOUR AU - Gilabert-Estellés, J. AU - Ramón, L. A. AU - España, F. AU - Gilabert, J. AU - Vila, V. AU - Réganon, E. AU - Castelló, R. AU - Chirivella, M. AU - Estellés, A. PY - 2007 DA - 2007// TI - Expression of angiogenic factors in endometriosis: its relation to fibrinolytic and metallproteinase (MMP) systems JO - Hum Reprod VL - 22 UR - https://doi.org/10.1093/humrep/dem149 DO - 10.1093/humrep/dem149 ID - Gilabert-Estellés2007 ER - TY - JOUR AU - Cosín, R. AU - Gilabert-Estellés, J. AU - Ramón, L. A. AU - Gómez-Lechón, M. J. AU - Gilabert, J. AU - Chirivella, M. AU - Braza-Boïls, A. AU - España, F. AU - Estellés, A. PY - 2010 DA - 2010// TI - Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis JO - Hum Reprod VL - 25 UR - https://doi.org/10.1093/humrep/dep419 DO - 10.1093/humrep/dep419 ID - Cosín2010 ER - TY - JOUR AU - Pepper, M. S. PY - 2001 DA - 2001// TI - Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis JO - Arterioscler Thromb Vasc Biol VL - 21 UR - https://doi.org/10.1161/hq0701.093685 DO - 10.1161/hq0701.093685 ID - Pepper2001 ER - TY - JOUR AU - Poon, R. T. AU - Fan, S. AU - Wong, J. PY - 2001 DA - 2001// TI - Clinical implications of circulating angiogenic factors in cancer patients JO - J Clin Oncol VL - 19 ID - Poon2001 ER - TY - JOUR AU - Zhang, H. AU - Liu, H. B. AU - Yuan, D. M. AU - Wang, Z. F. AU - Wang, Y. F. AU - Song, Y. PY - 2014 DA - 2014// TI - Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer JO - BMC Cancer VL - 14 UR - https://doi.org/10.1186/1471-2407-14-280 DO - 10.1186/1471-2407-14-280 ID - Zhang2014 ER - TY - JOUR AU - Kotyza, J. AU - Havel, D. AU - Vrzalová, J. AU - Kulda, V. AU - Pesek, M. PY - 2010 DA - 2010// TI - Diagnostic and prognostic significance of inflammatory markers in lung cancer-associated pleural effusions JO - Int J Biol Markers VL - 25 ID - Kotyza2010 ER - TY - JOUR AU - Hooper, C. E. AU - Elvers, K. T. AU - Welsh, G. I. AU - Millar, A. B. AU - Maskell, N. A. PY - 2012 DA - 2012// TI - VEGF and sVEGFR-1 in malignant pleural effusions: association with survival and pleurodesis outcomes JO - Lung Cancer VL - 77 UR - https://doi.org/10.1016/j.lungcan.2012.03.006 DO - 10.1016/j.lungcan.2012.03.006 ID - Hooper2012 ER - TY - JOUR AU - Pedersen, H. AU - Brünner, N. AU - Francis, D. AU - Osterlind, K. AU - Rønne, E. AU - Hansen, H. H. AU - Danø, K. AU - Grøndahl-Hansen, J. PY - 1994 DA - 1994// TI - Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue JO - Cancer Res VL - 54 ID - Pedersen1994 ER - TY - JOUR AU - Pedersen, H. AU - Grøndahl-Hansen, J. AU - Francis, D. AU - Østerlind, K. AU - Hansen, H. H. AU - Danø, K. AU - Brünner, N. PY - 1994 DA - 1994// TI - Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma JO - Cancer Res VL - 54 ID - Pedersen1994 ER - TY - JOUR AU - Hirata, T. AU - Yonemori, K. AU - Hirakawa, A. AU - Shimizu, C. AU - Tamura, K. AU - Ando, M. AU - Katsumata, N. AU - Tanimoto, M. AU - Fujiwara, Y. PY - 2011 DA - 2011// TI - Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients JO - Eur Respir J VL - 38 UR - https://doi.org/10.1183/09031936.00171610 DO - 10.1183/09031936.00171610 ID - Hirata2011 ER - TY - STD TI - Korsic M, Badovinac S, Cucevic B, Janevski Z. Talc pleurodesis improves survival of patients with malignant pleural effusions: case-control study. Wien Klin Wochenschr. 2015;10 [Epub ahead of print]. ID - ref52 ER - TY - JOUR AU - Nasreen, N. AU - Mohammed, K. A. AU - Dowling, P. A. AU - Ward, M. J. AU - Galffy, G. AU - Antony, V. B. PY - 2000 DA - 2000// TI - Talc induces apoptosis in human malignant mesothelioma cells in vitro JO - Am J Respir Crit Care Med VL - 161 UR - https://doi.org/10.1164/ajrccm.161.2.9904123 DO - 10.1164/ajrccm.161.2.9904123 ID - Nasreen2000 ER - TY - JOUR AU - Najmunnisa, N. AU - Mohammed, K. A. AU - Brown, S. AU - Su, J. AU - Sriram, P. S. AU - Moudgil, B. AU - Loddenkemper, R. AU - Antony, V. B. PY - 2007 DA - 2007// TI - Talc mediates angiostasis in malignant pleural effusions via endostatin induction JO - Eur Respir J VL - 29 UR - https://doi.org/10.1183/09031936.00061606 DO - 10.1183/09031936.00061606 ID - Najmunnisa2007 ER -